Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective
Amyotrophic lateral sclerosis (ALS) is a progressive and lethal disease of motor neuron degeneration, leading to paralysis of voluntary muscles and death by respiratory failure within five years of onset. Frontotemporal dementia (FTD) is characterised by degeneration of frontal and temporal lobes, l...
Saved in:
Main Authors: | Stephanie A. Fernandes, Andrew G. L. Douglas, Miguel A. Varela, Matthew J. A. Wood, Yoshitsugu Aoki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Journal of Nucleic Acids |
Online Access: | http://dx.doi.org/10.1155/2013/208245 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo
by: Liam Kempthorne, et al.
Published: (2025-01-01) -
Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion
by: Mirjana Babić Leko, et al.
Published: (2019-01-01) -
NLS-binding deficient Kapβ2 reduces neurotoxicity via selective interaction with C9orf72-ALS/FTD dipeptide repeats
by: Kevin M. Kim, et al.
Published: (2025-01-01) -
A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD
by: Tristan X. McCallister, et al.
Published: (2025-01-01) -
C9orf72 Alleviates DSS‑Induced Ulcerative Colitis via the cGAS‐STING Pathway
by: Yue Wang, et al.
Published: (2025-01-01)